|
1
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee
WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007
WHO classification of tumours of the central nervous system. Acta
Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Johnson DR and O'Neill BP: Glioblastoma
survival in the United States before and during the temozolomide
era. J Neurooncol. 107:359–364. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Johnsson P, Lipovich L, Grandér D and
Morris KV: Evolutionary conservation of long non-coding RNAs;
sequence, structure, function. Biochim Biophys Acta.
1840:1063–1071. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tripathi V, Ellis JD, Shen Z, Song DY, Pan
Q, Watt AT, Freier SM, Bennett CF, Sharma A, Bubulya PA, et al: The
nuclear-retained noncoding RNA MALAT1 regulates alternative
splicing by modulating SR splicing factor phosphorylation. Mol
Cell. 39:925–938. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wilusz JE: Long noncoding RNAs: Re-writing
dogmas of RNA processing and stability. Biochim Biophys Acta.
1859:128–138. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Prensner JR and Chinnaiyan AM: The
emergence of lncRNAs in cancer biology. Cancer Discov. 1:391–407.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dinger ME, Amaral PP, Mercer TR, Pang KC,
Bruce SJ, Gardiner BB, Askarian-Amiri ME, Ru K, Soldà G, Simons C,
et al: Long noncoding RNAs in mouse embryonic stem cell
pluripotency and differentiation. Genome Res. 18:1433–1445. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mercer TR, Dinger ME, Sunkin SM, Mehler MF
and Mattick JS: Specific expression of long noncoding RNAs in the
mouse brain. Proc Natl Acad Sci USA. 105:716–721. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mercer TR, Qureshi IA, Gokhan S, Dinger
ME, Li G, Mattick JS and Mehler MF: Long noncoding RNAs in
neuronal-glial fate specification and oligodendrocyte lineage
maturation. BMC Neurosci. 11:142010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang X, Sun S, Pu JK, Tsang AC, Lee D,
Man VO, Lui WM, Wong ST and Leung GK: Long non-coding RNA
expression profiles predict clinical phenotypes in glioma.
Neurobiol Dis. 48:1–8. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Morey L and Helin K: Polycomb group
protein-mediated repression of transcription. Trends Biochem Sci.
35:323–332. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sparmann A and van Lohuizen M: Polycomb
silencers control cell fate, development and cancer. Nat Rev
Cancer. 6:846–856. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nunes M, Blanc I, Maes J, Fellous M,
Robert B and McElreavey K: NSPc1, a novel mammalian Polycomb gene,
is expressed in neural crest-derived structures of the peripheral
nervous system. Mech Dev. 102:219–222. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gong Y, Wang X, Liu J, Shi L, Yin B, Peng
X, Qiang B and Yuan J: NSPc1, a mainly nuclear localized protein of
novel PcG family members, has a transcription repression activity
related to its PKC phosphorylation site at S183. FEBS Lett.
579:115–121. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hu PS, Xia QS, Wu F, Li DK, Qi YJ, Hu Y,
Wei ZZ, Li SS, Tian NY, Wei QF, et al: NSPc1 promotes cancer stem
cell self-renewal by repressing the synthesis of all-trans retinoic
acid via targeting RDH16 in malignant glioma. Oncogene.
36:4706–4718. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gong Y, Yue J, Wu X, Wang X, Wen J, Lu L,
Peng X, Qiang B and Yuan J: NSPc1 is a cell growth regulator that
acts as a transcriptional repressor of p21Waf1/Cip1 via the RARE
element. Nucleic Acids Res. 34:6158–6169. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu X, Gong Y, Yue J, Qiang B, Yuan J and
Peng X: Cooperation between EZH2, NSPc1-mediated histone H2A
ubiquitination and Dnmt1 in HOX gene silencing. Nucleic Acids Res.
36:3590–3599. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Simon JA and Kingston RE: Mechanisms of
polycomb gene silencing: Knowns and unknowns. Nat Rev Mol Cell
Biol. 10:697–708. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Davidovich C, Zheng L, Goodrich KJ and
Cech TR: Promiscuous RNA binding by Polycomb repressive complex 2.
Nat Struct Mol Biol. 20:1250–1257. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gutschner T, Hämmerle M and Diederichs S:
MALAT1 - a paradigm for long noncoding RNA function in cancer. J
Mol Med (Berl). 91:791–801. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hirata H, Hinoda Y, Shahryari V, Deng G,
Nakajima K, Tabatabai ZL, Ishii N and Dahiya R: Long noncoding RNA
MALAT1 promotes aggressive renal cell carcinoma through Ezh2 and
interacts with miR-205. Cancer Res. 75:1322–1331. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Qi Y, Ooi HS, Wu J, Chen J, Zhang X, Tan
S, Yu Q, Li YY, Kang Y, Li H, et al: MALAT1 long ncRNA promotes
gastric cancer metastasis by suppressing PCDH10. Oncotarget.
7:12693–12703. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lu Q, Ren S, Lu M, Zhang Y, Zhu D, Zhang X
and Li T: Computational prediction of associations between long
non-coding RNAs and proteins. BMC Genomics. 14:6512013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Δ Δ C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yao J, Zhou B, Zhang J, Geng P, Liu K, Zhu
Y and Zhu W: A new tumor suppressor lncRNA ADAMTS9-AS2 is regulated
by DNMT1 and inhibits migration of glioma cells. Tumour Biol.
35:7935–7944. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Laugesen A and Helin K: Chromatin
repressive complexes in stem cells, development, and cancer. Cell
Stem Cell. 14:735–751. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yap KL, Li S, Muñoz-Cabello AM, Raguz S,
Zeng L, Mujtaba S, Gil J, Walsh MJ and Zhou MM: Molecular interplay
of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by
polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell.
38:662–674. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kotake Y, Nakagawa T, Kitagawa K, Suzuki
S, Liu N, Kitagawa M and Xiong Y: Long non-coding RNA ANRIL is
required for the PRC2 recruitment to and silencing of p15(INK4B)
tumor suppressor gene. Oncogene. 30:1956–1962. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hu X, Feng Y, Zhang D, Zhao SD, Hu Z,
Greshock J, Zhang Y, Yang L, Zhong X, Wang LP, et al: A functional
genomic approach identifies FAL1 as an oncogenic long noncoding RNA
that associates with BMI1 and represses p21 expression in cancer.
Cancer Cell. 26:344–357. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gupta RA, Shah N, Wang KC, Kim J, Horlings
HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al: Long
non-coding RNA HOTAIR reprograms chromatin state to promote cancer
metastasis. Nature. 464:1071–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ji Q, Liu X, Fu X, Zhang L, Sui H, Zhou L,
Sun J, Cai J, Qin J, Ren J, et al: Resveratrol inhibits invasion
and metastasis of colorectal cancer cells via MALAT1 mediated
Wnt/β-catenin signal pathway. PLoS One. 8:e787002013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shen L, Chen L, Wang Y, Jiang X, Xia H and
Zhuang Z: Long noncoding RNA MALAT1 promotes brain metastasis by
inducing epithelial-mesenchymal transition in lung cancer. J
Neurooncol. 121:101–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang J, Su L, Chen X, Li P, Cai Q, Yu B,
Liu B, Wu W and Zhu Z: MALAT1 promotes cell proliferation in
gastric cancer by recruiting SF2/ASF. Biomed Pharmacother.
68:557–564. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li H, Fan R, Sun M, Jiang T and Gong Y:
Nspc1 regulates the key pluripotent Oct4-Nanog-Sox2 axis in P19
embryonal carcinoma cells via directly activating Oct4. Biochem
Biophys Res Commun. 440:527–532. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fantes J, Ragge NK, Lynch SA, McGill NI,
Collin JR, Howard-Peebles PN, Hayward C, Vivian AJ, Williamson K,
van Heyningen V, et al: Mutations in SOX2 cause anophthalmia. Nat
Genet. 33:461–463. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Amaral PP, Neyt C, Wilkins SJ,
Askarian-Amiri ME, Sunkin SM, Perkins AC and Mattick JS: Complex
architecture and regulated expression of the Sox2ot locus during
vertebrate development. RNA. 15:2013–2027. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Askarian-Amiri ME, Seyfoddin V, Smart CE,
Wang J, Kim JE, Hansji H, Baguley BC, Finlay GJ and Leung EY:
Emerging role of long non-coding RNA SOX2OT in SOX2 regulation in
breast cancer. PLoS One. 9:e1021402014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shahryari A, Rafiee MR, Fouani Y, Oliae
NA, Samaei NM, Shafiee M, Semnani S, Vasei M and Mowla SJ: Two
novel splice variants of SOX2OT, SOX2OT-S1, and SOX2OT-S2 are
coupregulated with SOX2 and OCT4 in esophageal squamous cell
carcinoma. Stem Cells. 32:126–134. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Shahryari A, Jazi MS, Samaei NM and Mowla
SJ: Long non- coding RNA SOX2OT: Expression signature, splicing
patterns, and emerging roles in pluripotency and tumorigenesis.
Front Genet. 6:1962015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Shi XM and Teng F: Up-regulation of long
non-coding RNA Sox2ot promotes hepatocellular carcinoma cell
metastasis and correlates with poor prognosis. Int J Clin Exp
Pathol. 8:4008–4014. 2015.PubMed/NCBI
|
|
41
|
Zhang Y, Yang R, Lian J and Xu H: lncRNA
Sox2ot overexpression serves as a poor prognostic biomarker in
gastric cancer. Am J Transl Res. 8:5035–5043. 2016.PubMed/NCBI
|
